Spinal muscular atrophy

SMA · Neurology · 3 drugs · 3 indications

Genetic motor neuron disease.
Competitive Landscape (3 drugs)
DrugCompanyMechanismModalityRouteStage
EmugrobartROG.SWAnti-Myostatin/ActivinAntibodySCPHASE3
ZolgensmaNVSSMN1 gene replacementGene therapyIVAPPROVED
EvrysdiROG.SWSMN2 splicing modifierSMN2 splicing modifierOralAPPROVED
Indications (3)
Muscle Wasting Diseases (SMA/FSHD)
Emugrobart PHASE3
SMA
Evrysdi APPROVED
Spinal muscular atrophy (pediatric)
Zolgensma APPROVED
Data from Supabase · Updated 2026-03-24